Skip to main content
. 2018 Sep 17;17:1533033818791794. doi: 10.1177/1533033818791794

Figure 1.

Figure 1.

The positive detection rate (sensitivity) of the mSEPT9 assay for NED (normal control), HP, adenoma, and CRC stage 0-IV using the 2/3 algorithm. The number of patients for each group was 300, 122, 67, 103, and 568 for CRC, Adenoma, Other GID, HP, and NED, respectively, and was 23, 42, 99, 124, and 12 for Stage 0, I, II, III, and IV CRC, respectively. CRC indicates colorectal cancer; GID, gastrointestinal disease; HP, hyperplastic polyps; NED, no evidence of disease.